UK Watchdog Says UnitedHealth Takeover Of EMIS Could Hurt National Health Service
The UK competition regulator released a statement on Friday that the initial investigation into UnitedHealth’s 1.24 billion-pound acquisition of EMIS could reduce competition, leading to potentially negative outcomes for National Health Service, patients, and taxpayers.
The Competition and Markets Authority said the deal to combine the healthcare software and data specialists could lead to lower quality and more expensive software options for the NHS.
Related: DOJ To Appeal Loss In UnitedHealth-Change Merger Challenge
In particular, competition could be substantially reduced in the so-called population health management and medicines-optimization software markets, which enable the safe and effective use of medicines, the CMA said.
The takeover offer was first disclosed in June 2022, and was made by Bordeaux an affiliate of Optum Health Solutions, and subsidiary of UnitedHealth.
The CMA is concerned the deal could affect services provided by Optum’s competitors, as they rely on digital connections to the data EMIS holds, and integrations with EMIS’s electronic patient record system.
Featured News
FTC to Approve Exxon’s $64 Billion Deal with Pioneer Resources, Excludes
May 1, 2024 by
CPI
UK Competition Watchdog Raises Alarm Over Nvidia’s ARM Takeover
May 1, 2024 by
CPI
Sen. Klobuchar Urges Regulators to Probe Collusion in Health Care Pricing
May 1, 2024 by
CPI
Multiple States Join Tennessee’s Antitrust Lawsuit Against NCAA Over NIL Rules
May 1, 2024 by
CPI
NY AG Joins Suit Challenging NCAA’s Restrictions on Student Athlete NIL Rights
May 1, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI